Rubidium chloride: Difference between revisions
m Dating maintenance tags: {{Medrs}} |
|||
Line 94: | Line 94: | ||
*Rubidium chloride is an excellent non-invasive [[biomarker]]. The compound dissolves well in water and readily be taken up by [[organism]]s. Once broken in the body, Rb<sup>+</sup> replaces [[potassium|K<sup>+</sup>]] in tissues because they are from the same [[periodic table group|chemical group]].<ref name="McLean" /> An example of this is the use of a [[rubidium chloride rb-82|radioactive isotope]] to evaluate [[perfusion]] of [[myocardium|heart muscle]]. |
*Rubidium chloride is an excellent non-invasive [[biomarker]]. The compound dissolves well in water and readily be taken up by [[organism]]s. Once broken in the body, Rb<sup>+</sup> replaces [[potassium|K<sup>+</sup>]] in tissues because they are from the same [[periodic table group|chemical group]].<ref name="McLean" /> An example of this is the use of a [[rubidium chloride rb-82|radioactive isotope]] to evaluate [[perfusion]] of [[myocardium|heart muscle]]. |
||
*Rubidium chloride [[Transformation (genetics)|transformation]] for [[competence (biology)|competent cells]] is arguably the compound's most abundant use. Cells treated with a [[Tonicity#Hypotonicity|hypotonic]] solution containing RbCl expand. As a result, the expulsion of membrane proteins allows negatively charged [[DNA]] to bind.<ref name="New" /> |
*Rubidium chloride [[Transformation (genetics)|transformation]] for [[competence (biology)|competent cells]] is arguably the compound's most abundant use. Cells treated with a [[Tonicity#Hypotonicity|hypotonic]] solution containing RbCl expand. As a result, the expulsion of membrane proteins allows negatively charged [[DNA]] to bind.<ref name="New" /> |
||
* RbCl has been used as an [[antidepressant]] in [[Europe]] under the trade name '''Rubinorm''' in doses ranging from 180 to 720 mg.<ref name="isbn0-658-00291-0" /><ref name="isbn1-58890-299-4" />{{medrs|date=March 2017}} It increases [[dopamine]] and [[norepinephrine]] levels and has [[stimulant|stimulating]] effects, hence it is useful for [[anergic]] and [[apathetic]] depressives.<ref name="isbn0-658-00291-0" />{{medrs|date=March 2017}} |
* RbCl has been used as an [[antidepressant]] in [[Europe]] under the trade name '''Rubinorm''' in doses ranging from 180 to 720 mg.<ref name="isbn0-658-00291-0" /><ref name="isbn1-58890-299-4" />{{medrs|date=March 2017}} It increases [[dopamine]] and [[norepinephrine]] levels and has [[stimulant|stimulating]] effects, hence it is useful for [[anergic]] and [[apathetic]] depressives.<ref name="PlacidiDell'Osso2012">{{cite book|author1=Gian F. Placidi|author2=Liliana Dell'Osso|author3=Giuseppe Nistico|coauthors=Hagop S. Akiskal|title=Recurrent Mood Disorders: New Perspectives in Therapy|url=https://books.google.com/books?id=pIvcBQAAQBAJ&pg=PT293|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-3-642-76646-6|pages=293–}}</ref><ref name="isbn0-658-00291-0" />{{medrs|date=March 2017}} |
||
==References== |
==References== |
Revision as of 22:53, 12 April 2017
Names | |
---|---|
Other names
rubidium(I) chloride
| |
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChemSpider | |
ECHA InfoCard | 100.029.310 |
PubChem CID
|
|
RTECS number |
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
RbCl | |
Molar mass | 120.921 g/mol |
Appearance | white crystals hygroscopic |
Density | 2.80 g/cm3 (25 °C) 2.088 g/mL (750 °C) |
Melting point | 718 °C (1,324 °F; 991 K) |
Boiling point | 1,390 °C (2,530 °F; 1,660 K) |
77 g/100mL (0 °C) 91 g/100 mL (20 °C) 130 g/100 mL (100 °C) | |
Solubility in methanol | 1.41 g/100 mL |
−46.0·10−6 cm3/mol | |
Refractive index (nD)
|
1.5322 |
Thermochemistry | |
Heat capacity (C)
|
52.4 J K−1 mol−1 |
Std molar
entropy (S⦵298) |
95.9 J K−1 mol−1 |
Std enthalpy of
formation (ΔfH⦵298) |
−435.14 kJ/mol |
Hazards | |
NFPA 704 (fire diamond) | |
Flash point | Non-flammable |
Lethal dose or concentration (LD, LC): | |
LD50 (median dose)
|
4440 mg/kg (rat) |
Safety data sheet (SDS) | Fisher Scientific |
Related compounds | |
Other anions
|
Rubidium fluoride Rubidium bromide Rubidium iodide Rubidium astatide |
Other cations
|
Lithium chloride Sodium chloride Potassium chloride Caesium chloride Francium chloride |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Rubidium chloride is the chemical compound with the formula RbCl. This alkali metal halide is composed of rubidium and chlorine, and finds diverse uses ranging from electrochemistry to molecular biology.
Structure
In its gas phase, RbCl is diatomic with a bond length estimated at 2.7868 Å.[1] This distance increases to 3.285 Å for cubic RbCl, reflecting the higher coordination number of the ions in the solid phase.[2]
Depending on conditions, solid RbCl exists in one of three arrangements or polymorphs as determined with holographic imaging:[3]
Sodium chloride (octahedral 6:6)
The sodium chloride (NaCl) polymorph is most common. A cubic close-packed arrangement of chloride anions with rubidium cations filling the octahedral holes describes this polymorph.[4] Both ions are six-coordinate in this arrangement. This polymorph's lattice energy is only 3.2 kJ/mol less than the following structure's.[5]
Caesium chloride (cubic 8:8)
At high temperature and pressure, RbCl adopts the caesium chloride (CsCl) structure (NaCl and KCl undergo the same structural change at high pressures). Here, the chloride ions form a simple cubic arrangement with chloride anions occupying the vertices of a cube surrounding a central Rb+. This is RbCl's densest packing motif.[2] Because a cube has eight vertices, both ions' coordination numbers equal eight. This is RbCl's highest possible coordination number. Therefore, according to the radius ratio rule, cations in this polymorph will reach their largest apparent radius because the anion-cation distances are greatest.[4]
Sphalerite (tetrahedral 4:4)
The sphalerite polymorph of rubidium chloride is extremely rare, resulting in few structural studies. The lattice energy, however, for this formation is predicted to nearly 40.0 kJ/mol smaller than those of the preceding structures.[5]
Synthesis
The most common preparation of pure rubidium chloride involves the reaction of its hydroxide with hydrochloric acid, followed by recrystallization:[6]
- RbOH(aq) + HCl(aq) → RbCl(aq) + H2O(l)
Because RbCl is hygroscopic, it must be protected from atmospheric moisture, e.g. using a desiccator. RbCl is primarily used in laboratories. Therefore, numerous suppliers (see below) produce it in smaller quantities as needed. It is offered in a variety of forms for chemical and biomedical research.
Reactions
Rubidium chloride reacts with sulfuric acid to rubidium hydrogen sulfate.
Radioactivity
Every 18 mg of rubidium chloride is equivalent to approximately one banana equivalent dose due to the large fraction (27.8%) of naturally-occurring radioactive isotope rubidium-87.
Uses
- Rubidium chloride is used as a gasoline additive to improve its octane number.[7]
- Rubidium chloride has been shown to modify coupling between circadian oscillators via reduced photaic input to the suprachiasmatic nuclei. The outcome is a more equalized circadian rhythm, even for stressed organisms.[8]
- Rubidium chloride is an excellent non-invasive biomarker. The compound dissolves well in water and readily be taken up by organisms. Once broken in the body, Rb+ replaces K+ in tissues because they are from the same chemical group.[9] An example of this is the use of a radioactive isotope to evaluate perfusion of heart muscle.
- Rubidium chloride transformation for competent cells is arguably the compound's most abundant use. Cells treated with a hypotonic solution containing RbCl expand. As a result, the expulsion of membrane proteins allows negatively charged DNA to bind.[10]
- RbCl has been used as an antidepressant in Europe under the trade name Rubinorm in doses ranging from 180 to 720 mg.[11][12][unreliable medical source?] It increases dopamine and norepinephrine levels and has stimulating effects, hence it is useful for anergic and apathetic depressives.[13][11][unreliable medical source?]
References
- ^ Lide, D. R.; Cahill, P.; Gold, L. P. (1963). "Microwave Spectrum of Lithium Chloride". Journal of Chemical Physics. 40 (1): 156–159. doi:10.1063/1.1724853.
- ^ a b Wells, A. F. (1984). Structural Inorganic Chemistry. Oxford University Press. pp. 410, 444.
- ^ Kopecky, M.; Fábry, J.; Kub, J.; Busetto, E.; Lausi, A. (2005). "X-ray diffuse scattering holography of a centrosymmetric sample". Applied Physics Letters. 87 (23): 231914. doi:10.1063/1.2140084.
- ^ a b Shriver, D. F.; Atkins, P. W.; Cooper, H. L. (1990). "Chapter 2". Inorganic Chemistry. Freeman.
- ^ a b Pyper, N. C.; Kirkland, A. I.; Harding, J. H. (2006). "Cohesion and polymorphism in solid rubidium chloride". Journal of Physics: Condensed Matter. 18 (2): 683–702. doi:10.1088/0953-8984/18/2/023.
- ^ Winter, M. (2006). "Compounds of Rubidium". WebElements.
- ^ Budavari, S. (1996). The Merck index: an encyclopedia of chemicals, drugs, and biologicals. Rahway, NJ, U.S.A.: Merck. ISBN 0-911910-12-3.
- ^ Hallonquist, J.; Lindegger, M.; Mrosovsky, N. (1994). "Rubidium chloride fuses split circadian activity rhythms in hamsters housed in bright constant light". Chronobiology International. 11 (2): 65–71. doi:10.3109/07420529409055892. PMID 8033243.
- ^ Hougardy, E.; Pernet, P.; Warnau, M.; Delisle, J.; Grégoire, J.-C. (2003). "Marking bark beetle parasitoids within the host plant with rubidium for dispersal studies". Entomologia Experimentalis et Applicata. 108 (2): 107. doi:10.1046/j.1570-7458.2003.00073.x.
- ^ "RbCl Transformation Protocol". New England Biolabs. 2006.
- ^ a b Baumel, S. (2000). Dealing with depression naturally: complementary and alternative therapies for restoring emotional health. Los Angeles: Keats Pub. p. 101. ISBN 0-658-00291-0.
- ^ Lake, J. A. (2006). Textbook of Integrative Mental Health Care. New York: Thieme Medical Publishers. p. 165. ISBN 1-58890-299-4.
- ^ Gian F. Placidi; Liliana Dell'Osso; Giuseppe Nistico (6 December 2012). Recurrent Mood Disorders: New Perspectives in Therapy. Springer Science & Business Media. pp. 293–. ISBN 978-3-642-76646-6.
{{cite book}}
: Unknown parameter|coauthors=
ignored (|author=
suggested) (help)